The Anticoagulation Market is witnessing a transformation due to technological innovations. Development of personalized medicine, AI-based monitoring tools, and improved diagnostic equipment allows physicians to better manage anticoagulation therapy. Direct Oral Anticoagulants (DOACs) have reduced the need for regular monitoring compared to older medications, improving patient adherence. Digital healthcare platforms are also playing a crucial role by providing real-time monitoring and data analytics, which enhance treatment efficacy. Wearable devices and mobile health apps can alert patients and doctors to irregularities in coagulation, preventing complications. These technologies not only reduce healthcare costs but also improve patient quality of life. As patients increasingly adopt telemedicine and remote care solutions, the demand for technology-integrated anticoagulants is expected to grow. Pharmaceutical companies are responding by incorporating digital support and monitoring into their drug offerings. This technological shift is helping the market expand across regions, particularly in areas where healthcare access is limited, creating a global opportunity for growth.